InsiderRadarUS · Europe
Account

This page is free to read, and it stops after 5 rows. Those are the 5 most recently posted filings for this company, out of 6. Reading the whole list, and what each filing says: its issues, the agencies contacted and the lobbyists named, is part of the subscription. So is sorting the list by the reported amount. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

No chart, because no filing here reports an amount. A registration and a “no activity” report carry none by design, and a filing below $5,000 ticks a box instead of stating a figure. Those are three different things and the list below says which is which.

Recent activity

Register facts only. Everything on this page comes from filings made under the Lobbying Disclosure Act of 1995 and kept by the Secretary of the Senate. We read the filings, we link a client to a listed company where a reviewed rule allows it, and we add nothing else. No score, no ranking and no judgement is attached to lobbying on this site. See the methodology and about this site.

5 of 6 filings
The most recently posted lobbying filings for VNDA
RegistrantFilingAmountPosted SourceRegistrantAmountFilingAll amountsPosted Source
MANATOS & MANATOSfor VANDA PHARMACEUTICALS INC1st Quarter - Report1st Quarter 2025under $5,000as reportedposted Apr 8, 2025Apr 8, 2025LD-2 at lda.govMANATOS & MANATOSfor VANDA PHARMACEUTICALS INCunder $5,000as reported · Apr 81st Quarter - Report1st Quarter 2025under $5,000as reportedApr 8, 2025LD-2 at lda.gov
MANATOS & MANATOSfor VANDA PHARMACEUTICALS INC4th Quarter - Report4th Quarter 2024under $5,000as reportedposted Jan 14, 2025Jan 14, 2025LD-2 at lda.govMANATOS & MANATOSfor VANDA PHARMACEUTICALS INCunder $5,000as reported · Jan 144th Quarter - Report4th Quarter 2024under $5,000as reportedJan 14, 2025LD-2 at lda.gov
MANATOS & MANATOSfor VANDA PHARMACEUTICALS INC3rd Quarter - Report3rd Quarter 2024under $5,000as reportedposted Oct 15, 2024Oct 15, 2024LD-2 at lda.govMANATOS & MANATOSfor VANDA PHARMACEUTICALS INCunder $5,000as reported · Oct 15, 20243rd Quarter - Report3rd Quarter 2024under $5,000as reportedOct 15, 2024LD-2 at lda.gov
MANATOS & MANATOSfor VANDA PHARMACEUTICALS INC2nd Quarter - Report2nd Quarter 2024under $5,000as reportedposted Jul 20, 2024Jul 20, 2024LD-2 at lda.govMANATOS & MANATOSfor VANDA PHARMACEUTICALS INCunder $5,000as reported · Jul 20, 20242nd Quarter - Report2nd Quarter 2024under $5,000as reportedJul 20, 2024LD-2 at lda.gov
MANATOS & MANATOSfor VANDA PHARMACEUTICALS INC1st Quarter - Report1st Quarter 2024under $5,000as reportedposted Apr 24, 2024Apr 24, 2024LD-2 at lda.govMANATOS & MANATOSfor VANDA PHARMACEUTICALS INCunder $5,000as reported · Apr 24, 20241st Quarter - Report1st Quarter 2024under $5,000as reportedApr 24, 2024LD-2 at lda.gov

The link between the client names above and VNDA is a reviewed rule of ours, not something the filing states: an LD-2 names a client and carries no ticker, no CIK and no LEI.